Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Apellis Pharmaceuticals Inc’s stock clocked out at $23.00, up 1.41% from its previous closing price of $22.68. In other words, the price has increased by $1.41 from its previous closing price. On the day, 3.0 million shares were traded. APLS stock price reached its highest trading level at $23.1 during the session, while it also had its lowest trading level at $21.92.
Ratios:
To gain a deeper understanding of APLS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.81 and its Current Ratio is at 4.25. In the meantime, Its Debt-to-Equity ratio is 2.06 whereas as Long-Term Debt/Eq ratio is at 2.03.
On November 21, 2024, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $31.
On October 25, 2024, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $25.RBC Capital Mkts initiated its Sector Perform rating on October 25, 2024, with a $25 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when Chopas James George sold 183 shares for $24.82 per share. The transaction valued at 4,543 led to the insider holds 47,955 shares of the business.
Chopas James George bought 183 shares of APLS for $4,543 on Mar 17 ’25. On Mar 05 ’25, another insider, Watson David O., who serves as the General Counsel of the company, sold 5,569 shares for $25.10 each. As a result, the insider received 139,789 and left with 138,730 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLS now has a Market Capitalization of 2886867968 and an Enterprise Value of 2900345600. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.69 while its Price-to-Book (P/B) ratio in mrq is 12.53. Its current Enterprise Value per Revenue stands at 3.712 whereas that against EBITDA is -17.774.
Stock Price History:
The Beta on a monthly basis for APLS is 0.70, which has changed by -0.58965206 over the last 52 weeks, in comparison to a change of 0.101756096 over the same period for the S&P500. Over the past 52 weeks, APLS has reached a high of $58.51, while it has fallen to a 52-week low of $21.70. The 50-Day Moving Average of the stock is -13.66%, while the 200-Day Moving Average is calculated to be -28.09%.
Shares Statistics:
It appears that APLS traded 1.86M shares on average per day over the past three months and 2738500 shares per day over the past ten days. A total of 124.50M shares are outstanding, with a floating share count of 104.48M. Insiders hold about 16.76% of the company’s shares, while institutions hold 99.36% stake in the company. Shares short for APLS as of 1741910400 were 19313821 with a Short Ratio of 10.36, compared to 1739491200 on 17341085. Therefore, it implies a Short% of Shares Outstanding of 19313821 and a Short% of Float of 21.0.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
